#AIEye
#Podcast 698: #Stocks discussed: (NYSE: $GWRE) (ASX:BRN) #artificialintelligence
Gradient
AI Joins Guidewire Insurtech Vanguards Program, and BrainChip Joins Arm AI
Partner Program
Global
#AI in #DrugDiscovery Market to Reach $9.1B by 2030
Vancouver, Kelowna, Delta, BC – May 23, 2022 – Investorideas.com,
a global investor news source covering Artificial Intelligence (AI) brings
you today’s edition of The
AI Eye-watching stock news, deal tracker and advancements in
artificial intelligence.
Listen
to today’s podcast:
https://www.investorideas.com/Audio/Podcasts/2022/052322-AI-Eye.mp3
Read
this in full at https://www.investorideas.com/news/2022/artificial-intelligence/05231GWRE-BRN.asp
Today’s
Column- The
AI Eye- Watching stock news, deal tracker and advancements
in artificial intelligence
Stocks
discussed: (NYSE:GWRE) (ASX:BRN)
Private firm Gradient AI, an enterprise software
provider of AI solutions for the insurance industry, has announced that it has joined the Insurtech
Vanguards program led by tech firm Guidewire Software, Inc. (NYSE:GWRE). According to the press release,
Insurtech Vanguards is “a community of select startups and technology providers
that are bringing novel solutions to the P&C industry,” wherein Gradient AI
will “help insurers learn about the newest insurtechs and how to best leverage
them.” Laura Drabik, Guidewire’s chief evangelist, commented:
“Gradient
AI is an effective, innovative, and proven insurance solution providing
insurers the intelligence needed to significantly improve their efficiency and
profitability in claims and underwriting operations. We are thrilled to welcome
Gradient AI as part of our program so our mutual customers can harness the
powerful benefits of AI and its competitive advantages in pricing,
underwriting, and claims management.”
BrainChip Holdings Ltd. (ASX:BRN) has been accepted into the Arm AI Partner Program,
described as “an ecosystem of hardware and software specialists enabling
developers to deliver the next generation of AI solutions.” Joining the Arm
Program allows BrainChip to build out its own ecosystem for Akida, the
company’s neuromorphic processor. Jerome Nadel, BrainChip’s CMO, said:
"It's
valuable for BrainChip to be part of Arm's portfolio of partners as Arm is not
only a leading provider of AI technologies, but an industry influencer. Arm
offers us another channel to give end users access to Akida, the world's first
commercial neuromorphic AI accelerator, and to foster the development of
best-in-class AI products and applications."
Global
AI in Drug Discovery Market to Reach $9.1B by 2030
Research published by ReportLinker finds that the global AI in Drug
Discovery market is projected to reach $9.1 billion USD by 2030, registering a
compound annual growth rate (CAGR) of 29.4 percent in the forecast period
2022-30. An excerpt from the report’s description outlines the adoption of AI
as a response to the COVID-19 pandemic:
The
pandemic has made the adoption of AI more widespread in the pharma industry. AI
and its related platforms aim to enhance medical imaging and diagnostics,
management of chronic diseases, and drug designing. The overall human hours
spent would be far more in comparison to the AI system scanning the same data,
which reduces overall cost and is a more feasible approach.
Sam Mowers, Investorideas.com
Read and
hear other editions of the AI Eye
For a list of
artificial intelligence stocks on Investorideas.com visit
here
About Investorideas.com -
News that Inspires Big Investing Ideas
Investorideas.com
publishes breaking stock news, third party stock research, guest posts and
original articles and podcasts in leading stock sectors. Learn about investing in stocks and get
investor ideas in cannabis, crypto, AI and IoT, mining, sports biotech, water,
renewable energy, gaming and more. Investor Idea’s original branded content
includes podcasts and columns : Crypto Corner , Play
by Play sports and stock news , Investor Ideas Potcasts
Cannabis News and Stocks on the Move podcast ,
Cleantech
and Climate Change , Exploring
Mining , Betting
on Gaming Stocks Podcast and
the AI
Eye Podcast.
The
Investorideas.com podcasts are also available on Apple Podcasts , Audible , Spotify, Tunein, Stitcher,
Spreaker.com, iHeartRadio, Google Podcasts
and most audio platforms available.
Visit the Podcast page at Investorideas.com: https://www.investorideas.com/Audio/
Disclaimer/Disclosure: Investorideas.com is a digital publisher of
third party sourced news, articles and equity research as well as creates
original content, including video, interviews and articles. Original content
created by investorideas is protected by copyright laws other than syndication
rights. Our site does not make recommendations for purchases or sale of stocks,
services or products. Nothing on our sites should be construed as an offer or
solicitation to buy or sell products or securities. All investing involves risk
and possible losses. This site is currently compensated for news publication
and distribution, social media and marketing, content creation and more.
Disclosure is posted for each compensated news release, content published
/created if required but otherwise the news was not compensated for and was
published for the sole interest of our readers and followers. Contact
management and IR of each company directly regarding specific questions. More
disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about
publishing your news release and our other news services on the
Investorideas.com newswire https://www.investorideas.com/News-Upload/ Global investors must
adhere to regulations of each country. Please read Investorideas.com privacy
policy: https://www.investorideas.com/About/Private_Policy.asp
The AI Eye-
Watching stock news, deal tracker and advancements in artificial
intelligence is an original content brand of Investorideas.com
Follow us on Twitter https://twitter.com/Investorideas
Follow us on Facebook https://www.facebook.com/Investorideas
Follow us on YouTube https://www.youtube.com/c/Investorideas
Contact
Investorideas.com
800 665 0411
Get more Technology stock investor
ideas - news, articles, podcasts and stock directories
No comments:
Post a Comment